Description
XL-228isathirdgenerationinhibitorofAblthatshowsefficacyinavarietyofcelllines,includingthoseexhibitingT315Imutations.XL-228displaysanticancerchemotherapeuticactivityandiscurrentlyinclinicaltrialsasapotentialtreatmentforchronicmyelogenousleukemia(CML).